98%
921
2 minutes
20
Objectives: Eye disease and vision impairment are known to be associated with reduced mental well-being, but less is known about the well-being of people with near-normal levels of vision. Here, we examined the association between self-reported eyesight and mental well-being, controlling for eye disease, mental ill-health and demographic factors, for adults with a wide range of age and vision.
Design: Population-based cross-sectional study.
Participants: 7705 adults (56% women; median age 49 years, range 16-104 years) who participated in the Health Survey for England 2013, self-reported their eyesight status and completed the Warwick-Edinburgh Mental Well-Being Scale.
Primary Outcome Measure: Mental well-being, controlling for self-reported mental ill health, self-reported eye disease, age, sex, socioeconomic group and ethnic origin.
Results: Poorer self-reported eyesight was strongly associated with lower mental well-being (univariate linear model, F=94.7, p<0.001) and explained 5% of the variance in the outcome variable (R=0.047). Relative to reporting 'poor' vision, each subsequent level of vision predicted better well-being, with the exception of 'fair' vision, which was not significantly different from 'poor' reported vision. This association remained significant after controlling for self-reported mental ill health, self-reported eye disease, age, sex, socioeconomic group and ethnic origin.
Conclusions: Self-reported eyesight is strongly associated with mental well-being, irrespective of whether people have vision impairment or a diagnosed eye disease. This relationship exists in people with and without mental ill-health. Mental well-being should be considered in people with reduced eyesight, regardless of whether they have a diagnosed eye disease or mental ill-health. Interventions which improve vision may have a positive impact on mental well-being.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12359461 | PMC |
http://dx.doi.org/10.1136/bmjopen-2025-101753 | DOI Listing |
J Med Internet Res
September 2025
Department of Psychiatry, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
Background: Internet-based cognitive behavioral therapies (iCBTs) are typically categorized into 2 types: therapist-assisted and self-guided. Both formats have accumulated substantial evidence supporting their cost-effectiveness and efficacy in treating a range of mental health conditions. However, therapist-assisted iCBTs tend to show lower dropout rates than self-guided versions.
View Article and Find Full Text PDFJMIR Ment Health
September 2025
National Institute of Health and Care Research MindTech HealthTech Research Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Background: Cross-sector collaboration is increasingly recognized as essential for addressing complex health challenges, including those in mental health. Industry-academic partnerships play a vital role in advancing research and developing health solutions, yet differing priorities and perspectives can make collaboration complex.
Objective: This study aimed to identify key principles to support effective industry-academic partnerships, from the perspective of industry partners, and develop this into actionable guidance, which can be applied across sectors.
JMIR Res Protoc
September 2025
National Institute of Public Health, University of Southern Denmark, Copenhagen K, Denmark.
Background: The high and increasing rate of poor mental health among young people is a matter of global concern. Experiencing poor mental health during this formative stage of life can adversely impact interpersonal relationships, academic and professional performance, and future health and well-being if not addressed early. However, only a few of those in need seek help.
View Article and Find Full Text PDFNeuro Endocrinol Lett
September 2025
Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Background: Major depressive disorder (MDD) is associated with neuro-immune - metabolic - oxidative (NIMETOX) pathways.
Aims: To examine the connections among NIMETOX pathways in outpatient MDD (OMDD) with and without metabolic syndrome (MetS); and to determine the prevalence of NIMETOX aberrations in a cohort of OMDD patients.
Methods: We included 67 healthy controls and 66 OMDD patients and we assessed various NIMETOX pathways.